Acadia Pharmaceuticals (ACAD) Non-Current Assets (2010 - 2026)
Acadia Pharmaceuticals (ACAD) recorded Non-Current Assets of $518.36 million in Q2 2026, up 95.6% from $265 million a year earlier and up 1.8% from the prior quarter.
Acadia Pharmaceuticals (ACAD) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Acadia Pharmaceuticals reported Non-Current Assets of $502.08 million, up 101.3% from FY2024.
- Annual Non-Current Assets has increased for three straight years, with a five-year compound annual growth rate of 50.5% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $249.44 million in FY2024 (+87.8%), $132.83 million in FY2023 (+66.3%), $79.88 million in FY2022 (-2.9%) and $82.3 million in FY2021 (+26.6%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2010.
- On a year-over-year basis, Non-Current Assets has increased for 14 consecutive quarters, with growth averaging 68.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 101.3% in Q4 2025, against a decline of 2.9% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $509.21 million (Q1 2026), $502.08 million (Q4 2025) and $254.35 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Acadia Pharmaceuticals | 2.95 Bn | -526.50 Mn | 279.64 Mn | 518.36 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 518.36 Mn |
| Mar 31, 2026 | 509.21 Mn |
| Dec 31, 2025 | 502.08 Mn |
| Sep 30, 2025 | 254.35 Mn |
| Jun 30, 2025 | 265.00 Mn |
| Mar 31, 2025 | 261.42 Mn |
| Dec 31, 2024 | 249.44 Mn |
| Sep 30, 2024 | 188.58 Mn |
| Jun 30, 2024 | 185.18 Mn |
| Mar 31, 2024 | 179.81 Mn |
| Dec 31, 2023 | 132.83 Mn |
| Sep 30, 2023 | 133.37 Mn |
| Jun 30, 2023 | 150.14 Mn |
| Mar 31, 2023 | 152.46 Mn |
| Dec 31, 2022 | 79.88 Mn |
| Sep 30, 2022 | 80.94 Mn |
| Jun 30, 2022 | 80.25 Mn |
| Mar 31, 2022 | 82.03 Mn |
| Dec 31, 2021 | 82.30 Mn |
| Sep 30, 2021 | 76.76 Mn |
Acadia Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();